Project Grant K01HL184071
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Indiana University Indianapolis a Project Grant of $169,444.00 under the Cardiovascular Diseases Research program (CFDA 93.837) beginning September 5, 2025, with completion targeted for August 31, 2030. This award supports the co-development and pilot testing of a stress management intervention designed specifically for Black adults with elevated blood pressure and hypertension. The research addresses...
- Federal Grant Award Summary The University of Connecticut Health Center received a $155,452 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with a completion date of June 30, 2031. This award funds research evaluating the epidemiological impact and cost-effectiveness of integrated HIV and non-communicable disease (NCD) service delivery in Zambia. The project leverages data from a...
- Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $110,799 Project Grant to the University of Pittsburgh on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). Led by Clinical Psychologist Andrea Goldschmidt, Ph.D., this NHLBI Midcareer Award in Patient-Oriented Research supports the Ambulatory Study of Stress, Eating, and Reactivity in Teens (PROJECT ASSERT). The project will advance understanding of the complex associations between...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $123,368 to The Research Foundation for the State University of New York (SUNY ESF) on September 16, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This K01 career development award, which extends through August 31, 2030, supports research examining the effects of structural racism on cardiovascular disease (CVD) disparities in underserved populations. The project...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut Health Center a $293,395 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 15, 2025, with a completion date of July 31, 2028. This award supports the "Democratizing Access to Cleaner Residential Air" (DACRA) initiative, which investigates the efficacy and feasibility of low-cost Corsi-Rosenthal boxes as an intervention to reduce...
- Federal Grant Award Summary Temple University received a $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2027. Under this R03 award, Principal Investigator Gabriella McLoughlin, PhD, MS, will conduct research investigating the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Pittsburgh a Project Grant totaling $190,168 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 2, 2026, with completion targeted for April 30, 2031. This award supports Dr. Malamo Countouris' research program investigating strategies to reverse left ventricular remodeling in women with a history of preeclampsia who subsequently develop hypertension. The research...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $1,381,876 to the University of Alaska Fairbanks, with an award date of September 23, 2025 and ultimate completion date of July 31, 2027, under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Neqpiaput Iinruugut (Our Food is Medicine): Testing a Tribally-Driven Intervention to Prevent Heart Disease Among Alaska Native Communities," delivers...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded $169,992 to the University of Colorado-Denver on September 18, 2025, to support a mixed-methods research study titled "Start Strong." This K01 mentored career development award funds research investigating optimal antihypertensive medication initiation strategies and will generate evidence for a future pragmatic trial testing a...
- Federal Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation and Brown University affiliate, received a $391,392 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) effective September 8, 2025. The award supports development and feasibility testing of the Active, Nourished, and Empowered Teens (ANET) program, a modular nutrition and physical activity intervention designed to address...
The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut a Project Grant of $163,062 (awarded July 10, 2026; completion date June 30, 2031) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test a stress- and acceptance-based weight gain prevention (WGP) intervention tailored for Black women. This K01 career development award addresses a significant health disparity, as existing behavioral weight loss approaches have been developed primarily for white women and produce suboptimal outcomes in Black women. The intervention shifts focus from weight loss to weight stability, aligning with Black women's sociocultural preferences and potentially improving treatment uptake while supporting cardiovascular and metabolic health equity. The project will deliver research outputs across three primary aims: (1) examining relationships between physical activity, psychosocial, and environmental variables using existing cohort data; (2) developing and refining stress management and acceptance-based behavioral treatment components with 60 Black women participants; and (3) evaluating participants' experiences with the intervention components and their associations with weight-related behaviors. The award includes four integrated training goals to build the investigator's expertise in intervention optimization methodology, positioning the research to advance evidence-based, culturally responsive approaches to obesity prevention in a population with documented disparities in obesity prevalence and health outcomes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $163.1k | 7/10/26 |